youtube_live
Q2 2027 earnings • released • Revenue beat +5.11%
See resultschevron_right
4523:TYO
Eisai Co Ltd
¥5,186.00
arrow_upward
+0.31%(+16.00) 1D
Nov 13, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4523...
Open
¥5,152
High
¥5,216
Low
¥5,093
Mkt. cap
1.51T
Avg. vol.
1.35M
Volume
1.57M
Dividend
3.09%
Quarterly dividend
¥40
Ex-dividend date
Sep 29, 2026
P/E ratio
33.33
52-wk high
¥5,284
52-wk low
¥3,660
EPS
¥156
Shares outstanding
286.43M
No. of employees
11K
Open
¥5,152
High
¥5,216
Low
¥5,093
Mkt. cap
1.51T
Avg. vol.
1.35M
Volume
1.57M
Dividend
3.09%
Quarterly dividend
¥40
Ex-dividend date
Sep 29, 2026
P/E ratio
33.33
52-wk high
¥5,284
52-wk low
¥3,660
EPS
¥156
Shares outstanding
286.43M
No. of employees
11K
News stories
From web sources and news partners
Yahoo Finance
·
19 hours ago
BioArctic (OM:BIOA B) Debuts At Home Alzheimer’s Pen In Japan
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10.5K
FoundedDec 6, 1941
HeadquartersBunkyo City, Tokyo, Japan
SectorHealth Care
IndustryPharmaceutical industry
Websiteeisai.co.jp